Health related quality of life after combined hormone replacement therapy: Randomised controlled trial

BMJ

Volumn 337, Issue 7669, 2008, Pages 550-553

  Welton, Amanda J ^a   Vickers, Madge R ^a   Kim, Joseph ^b   Ford, Deborah ^c   Lawton, Beverley A ^d   MacLennan, Alastair H ^e   Meredith, Sarah K ^c   Martin, Jeannett ^a   Meade, Tom W ^b  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c MRC CLINICAL TRIALS UNIT   (United Kingdom)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; PLACEBO;

ADULT; ARTHRALGIA; ARTICLE; BREAST TENDERNESS; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; EMOTION; FEMALE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MYALGIA; NIGHT SWEAT; POSTMENOPAUSE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEXUAL FUNCTION; SLEEP DISORDER; UTERUS; VAGINA BLEEDING; VAGINA DISCHARGE; VAGINAL DRYNESS; VASOMOTOR DISORDER; VISUAL ANALOG SCALE;

AGED; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ESTROGENS; FEMALE; HEALTH STATUS; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PROGESTINS; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; WOMEN'S HEALTH;

EID: 51949110031     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.a1190     Document Type: Article

References (14)

1. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 2002;288:321-33.
2. Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839-54
3. Brunner RL, Gass M, Aragaki A, Hays J, Granek I, Woods N, et al. Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the women's health initiative randomized clinical trial. Arch Intern Med 2005;165:1976-86.
4. Hlatky M, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA. Quality of life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the heart and estrogen/progestin replacement study (HERS) trial. JAMA 2002;287:591-7.
5. Vickers MR, Martin J, Meade TW; WISDOM Study Team. The women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial. BMC Womens Health 2007;7:2.
6. Vickers M, Meade T, Darbyshire J. WISDOM: history and early demise - was it inevitable? Climacteric 2002;5:317-25.
7. Vickers MR, MacLennan AH, Lawton B, Ford D, Martin J, Meredith SK, et al. Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women. BMJ 2007;335:239.
8. Szoeke CE, Cicuttini F, Guthrie J, Dennerstein L. Self-reported arthritis and the menopause. Climacteric 2005;8:49-55.
9. Maki PM, Gast MJ, Vieweg AJ, Burriss SW, Yaffe K. Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial. Neurology 2007;69:1322-30.
10. Zethraeus N, Johannesson M, Henriksson P, Strand RT. The impact of hormone replacement therapy on quality of life and willingness to pay. Br J Obstet Gynaecol 1997;104:1191-5.
11. Pines A, Sturdee DW, Birkhauser MH, Schneider HPG, Gambacciani M, Panay N. IMS updated recommendations on postnatal hormone therapy. Climacteric 2007;10:181-94.
12. Salpeter SR, Walsh JME, Greyber E, Ormiston TM, Salpeter EE. Mortality associated with hormone replacement therapy in younger and older women. J Gen Intern Med 2004;19:791-804.
13. Salpeter SR, Walsh JME, Greyber E, Salpeter EE. Coronary heart disease events associated with hormone therapy in younger and older women: a meta-analysis. J Gen Int Med 2006;21:363-6.
14. Phillips LS, Langer RD. Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis. Fertil Steril 2005;83:558-66.